Related Experiment Video
Updated: May 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus: here comes all-oral treatment
Mohannad Dugum1, Robert O'Shea
1Department of Internal Medicine, Medicine Institute, Cleveland Clinic.
Abstract:
Treatment for chronic hepatitis C virus (HCV) infection is evolving rapidly. The approval in 2013 of two new direct-acting antivirals-sofosbuvir (a polymerase inhibitor) and simeprevir (a second-generation protease inhibitor)-opens the door for an all-oral regimen, potentially avoiding interferon and its harsh side effects. Other direct-acting antivirals are under development.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Treatment Resistent Cancers
Oral Drug Delivery Systems: Introduction

